TrialBMC infectious diseases2024

Nebulized inhalation of plasma-activated water in the treatment of progressive moderate COVID-19 patients with antiviral treatment failure: a randomized controlled pilot trial.

Heng Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.